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Sarcomeric myosin heavy chains (MyHC) are the major contractile proteins of cardiac and skeletal muscles and belong to class II MyHC. In
this study the sequences of nine sarcomeric MyHC isoforms were obtained by combining assembled contigs of the dog genome draft available in
the NCBI database. With this information available the dog becomes the second species, after human, for which the sequences of all members of
the sarcomeric MyHC gene family are identified. The newly determined sequences of canine MyHC isoforms were aligned with their orthologs in
mammals, forming a set of 38 isoforms, to search for the molecular features that determine the structural and functional specificity of each type of
isoform. In this way the structural motifs that allow identification of each isoform and are likely determinants of functional properties were
identified in six specific regions (surface loop 1, loop 2, loop 3, converter, MLC binding region, and S2 proximal segment).
© 2006 Elsevier Inc. All rights reserved.Keywords: Dog; Genome; Sarcomere; Myosin heavy chain; Loops; Muscle contractionThe interaction between myosin and actin is the molecular
basis of muscle contraction and ATP hydrolyzed by myosin is
the energy source for mechanical power output. The myosin
molecules incorporated in the myofibrils of striated muscles
belong to class II [1] and are often identified as “sarcomeric
myosins.” Sarcomeric myosins are heterohexamers consisting of
two myosin heavy chains (MyHC) and two pairs of two distinct
myosin light chains (MyLC; essential and regulatory light chains
or ELC and RLC). MyHC isoforms determine the contractile
properties of the myosin molecule and are considered the
molecular markers of the fiber type [2]. For this reason the fiber-
type names are generally used for sarcomeric myosin isoforms.
In all mammalian species examined until now nine distinct
MyHC isoforms (paralogous isoforms) are expressed in striated
cardiac and skeletal muscles and incorporated in the thick
filaments. The nine MyHC isoforms are coded by distinct genes
[1] and can be grouped in three subfamilies [3,4] based on their⁎ Corresponding author. Fax: +390498275301.
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doi:10.1016/j.ygeno.2006.08.004chromosomal localization. In the human genome, a first
subfamily of genes is localized on chromosome 17 and includes
three fast isoforms expressed in adult fast skeletal muscle fibers
(called 2A, 2X, and 2B, coded by the genes MYH2, MYH1, and
MYH4, respectively), two developmental or transitional iso-
forms expressed during the early stage of muscle development
(embryonic; gene MYH3) or during the neonatal period
(neonatal or perinatal; gene MYH8), and a sixth isoform
expressed only in extraocular muscles (EO; gene MYH13). A
second subfamily, localized on chromosome 14, includes the
two isoforms specific for cardiac muscle, the slow MyHC
isoform (also called β or type 1, coded by the gene MYH7),
expressed in ventricular myocardium and in slow skeletal
muscle fibers, and the α-cardiac (coded by gene MYH 6)
expressed in atrial myocardium and in some specialized skeletal
muscles such as the masseter muscle. Finally, the third
subfamily is composed of one member, the masticatory isoform
(2M or M; gene MYH16), the gene being localized on human
chromosome 7 [5] and the protein present only in jaw muscles
of carnivores and some primates [6], but not in humans [7]. The
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other genes (MYH14 and MYH15 [8]) still waits to be
confirmed by expression studies.
A large body of evidence has been accumulated on the
functional diversity among MyHC isoforms. In all animal
species investigated until now the sliding velocity of myosin
filaments measured in in vitro motility assays or in muscle
fibers increases in the order β/1 or slow, α-cardiac, 2A, 2X,
and 2B [9,10]. Less information is available on the develop-
mental isoforms embryonic and perinatal (hereafter called Emb
and Peri) and on the specialized isoforms EO and 2M. There
are, however, indications that Emb and Peri are associated with
low values of sliding filament speed, whereas high values of
movement speed are generated by EO and 2M [11,12]. ATPase
activity follows a similar trend, increasing from β/1 to α-
cardiac and from 2A to 2X and 2B [13]. MyHC 2M has been
shown to possess very high enzymatic activity [14]. The
variations of the functional properties likely find their basis in
the diversity in the primary structure of the MyHC isoforms.
Three surface loops (loop 1, loop 2, and loop 3) have been
suggested by previous comparative studies as possible
determinants of the structural and functional features of
various isoforms [15,16]. Mutation studies have given support
to those hypotheses [17,18]. The converter domain has been
shown to determine functional properties of MyHC in insect
muscles [19], and other two potentially relevant regions are the
light-chain-binding α-helix and the proximal part of the S2
subfragment where binding sites for MyBP-C are localized.
Among mammalian species, the nucleotide and amino acid
sequences of all nine sarcomeric MyHC genes are known in
humans (complete sequences for type β/1, 2A, 2X, 2B, EO,
Emb, Peri, and α-cardiac and partial sequence for 2M), whereas
the sequences of the four adult skeletal muscle MyHC are
available for the pig (type β/1, 2A, 2X, and 2B) and cattle (type
β/1, 2A, 2X, and 2B), and only three adult skeletal muscle
MyHC (type β/1, 2A, and 2X) have been sequenced for the
horse. More scattered data are available for laboratory animals
such as the mouse (type β/1, 2A, 2X, and α-cardiac), the rat
(typeβ/1,α-cardiac, and Emb), and the rabbit (type 2X and EO).
The MyHC 2M sequence of the cat has been reported by Hoh
and co-workers [5].
The reconstruction of the phylogenetic relations among the
knownMyHC isoforms based on a tree of 18 sarcomeric isoforms
including scallop and several vertebrate (humans, chicken, quail,
rabbit, rat) isoforms [4] and on a tree of all class II humanMyHC
isoforms [8] has been recently published. The analysis has
revealed the presence in mammalian genomes of three groups,
2M, fast/developmental (2A, 2X, 2B, Peri, Emb, and EO), and
slow/cardiac (α and β/1), which coincide with the three
subfamilies with distinct chromosomal localizations mentioned
above.Although allMyHCderive froma common ancestor gene,
masticatory MyHC has diverged considerably from fast/devel-
opmental and slow/cardiac isoforms after gene duplications and
is now distantly related to the other mammalian fast/develop-
mental and slow/cardiac subclasses [4].
The first aim of this study was to identify the sequences of all
sarcomeric MyHC isoforms in the recently published caninegenome [20]. Several muscle diseases are of interest for vete-
rinarian medicine, and dog muscle adaptations in relation to
exercise are often studied. A precise analysis of skeletal muscles
in physiological and pathological conditions requires correct
and reliable fiber-type identification and this is based on MyHC
isoform expression (see above and [2]). The identification of the
sequences of MyHC isoforms is an essential step to develop
reliable tools to study their expression. The identification of the
9 canine MyHC isoforms brings to 38 the number of sarcomeric
MyHC sequences determined in various mammalian species.
This offers an unprecedented possibility of carrying out
extensive comparisons between paralogs and orthologs to
define which molecular features identify each specific type of
isoform. Thus, the second aim of this study was to exploit the
potential of information contained in the MyHC sequences, to
understand better the basis of the structural diversity of
sarcomeric myosin isoforms.
Results and discussion
The nucleotide sequences of nine MyHC isoforms, i.e., 2A,
2B, 2X, Emb, Peri, EO, β/1, α-cardiac, and 2M, were identified
in the draft of the dog genome available at the NCBI Dog
Genome Resources Web site. Exon and intron sequences were
generated for each isoform and the putative amino acid (aa)
sequences were deduced, as described under Methods. The
translation predicted an open reading frame of 1940 aa for 2A,
EO, and Emb MyHC; 1939 aa for 2B, 2X, and Peri MyHC; and
1935 aa for MyHC β/1. Only partial putative proteins,
composed of 1589 and 1880 aa, respectively, could be predicted
for α-cardiac and 2M MyHC. It must be emphasized that,
although it is relatively easy to recognize the MyHC-like
sequences in genomic DNA, it is more difficult to predict and
assemble all exons, generally about 40, that are present in a full-
length MyHC transcript.
All novel MyHC sequences were deposited with GenBank
and are also available in Supplementary Fig. 1, in which all the
sequences of mammalian MyHC isoforms considered in this
study are aligned. The accession numbers of the dog MyHC
isoforms are reported in Table 1, together with the accession
numbers of all other isoforms utilized for the comparative
analysis (see below). The availability of these data makes the
dog the second best known species, after human, with regard to
the MyHC isoform sequences.
By BLASTN analyses we could also localize each MyHC
gene in the dog genome. Three distinct localizations were found:
one cluster on chromosome 5 contains the fast isoforms (2A, 2X,
2B, Peri, Emb, EO), a second cluster on chromosome 8 includes
β/1 and α-cardiac MyHC, while MyHC 2M stands alone on
chromosome 6 (Fig. 1). Such cluster organization is similar to
that previously described for other mammalian species [3,23].
General comparison between canine MyHC isoforms and their
orthologs in other mammalian species
BLAST searches and sequence comparison revealed the
expected high levels of amino acid similarity between dog
Table 1
Accession numbers of the mammalian sarcomeric MyHC isoforms available on
the NCBI database
Isoform NCBI Accession No.
Canis 2X DQ227281
Canis 2B DQ227282
Canis 2A DQ227280
Canis Peri DQ227283
Canis Emb DQ227279
Canis EO DQ227284
Canis α DQ227286
Canis β/1 DQ227285
Canis 2M DQ227287
Homo 2X AF111785
Homo 2B AF111783
Homo 2A AF111784
Homo Peri M36769
Homo Emb X13988
Homo EO AF111782
Homo α D00943
Homo β/1 X52889
Rattus 2B XP_340819
Rattus 2X XP_213345
Rattus Emb X04267
Rattus α X15938
Rattus β/1 X15939
Mus 2A AAH08538
Mus 2X XP_137643
Mus α NM_010856
Mus β/1 AY056464
Sus 2A AB025260
Sus 2B AB025261
Sus 2X AB025262
Sus β/1 AB053226
Bos 2A AB059398
Bos 2X AB059399
Bos β/1 AB059400
Equus 2A AB088365
Equus 2X AB088366
Equus β/1 AB088367
Oryctolagus 2X U32574
Oryctolagus EO AF212148
Felis 2M U51472
Scallop MHC X55714
Scallop MyHC was used as outgroup.
Fig. 1. Chromosomal localization of the sarcomeric MyHC isoforms in the
canine genome.
Table 2
Identity at protein level between canine sarcomeric MyHC isoforms and their
orthologs in other mammalian species
MyHC Ortholog % Identity
(a) Canis 2B Sus 95
Rattus 95
Homo 95
(b) Canis 2X Sus 97
Bos 96
Mus 96
Equus 96
Homo 96
Oryctolagus 97
Rattus 97
(c) Canis 2A Sus 98
Bos 97
Equus 98
Homo 97
(d) Canis EO Homo 94
Oryctolagus 95
(e) Canis Emb Homo 98
Rattus 97
Canis Peri Homo 96
(f) Canis β/1 Sus 98
Bos 97
Mus 98
Equus 97
Homo 98
Rattus 98
(g) Canis 2M Felis 98
(h) a Rattus β/1 Mus β/1 99
Canis 2M Homo Peri 57
Canis 2M Mus β/1 60
Scallop Homo EO 51
Scallop Canis β/1 54
a The highest and the lowest examples of identity among mammalian
sarcomeric isoforms are given.
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mammals. Sequences of 38 MyHC isoforms belonging to
eight mammalian species (human, dog, pig, cattle, horse,
mouse, rat, rabbit, cat) and scallop MyHC were aligned using
DiAlign software. The proportion of nonidentical amino acids,
determined in paired comparison between all isoforms, is
reported in Supplementary Fig. 2. As expected [9,24], the
comparison between orthologs revealed the highest similarity
(e.g., more than 99% identity between rat and mouse β/1
MyHC), whereas the comparison between paralogs showed
greater diversity.
Canine MyHC isoforms were highly similar to the ortholo-
gous isoforms of other species. As can be seen in Table 2, the
identity was 95% forMyHC 2B, 96-97% for 2X, and 97-98% for
type 2A and type β/1. Among developmental isoforms the
percentage of identical amino acids was higher for MyHC Emb(97-98%) than for Peri (96%), whereas among isoforms
expressed in craniofacial muscles the identity was 98% for
MyHC 2M (only 1880 aa available) and 94-95% for MyHC EO.
The general rule that orthologs show higher identity than
paralogs finds few exceptions. For example, the porcine MyHC
2B is closer to MyHC 2X than toMyHC 2B of other species (see
also below, phylogenetic trees and Supplementary Fig. 2). The
diversity between paralogs (Table 2 and Supplementary Fig. 2) is
227L. Maccatrozzo et al. / Genomics 89 (2007) 224–236emphasized by low values of identity, e.g., 75-76% if α-cardiac
isoforms are compared with fast/developmental, and becomes
particularly evident for MyHC 2M. For example, dog MyHC
2M shows identity values between 57 and 60% with paralogous
dog MyHC isoforms, just slightly higher than those of scallop
MyHC, which is used as the outgroup (Table 2).
MyHC isoform comparison based on phylogenetic trees
The reconstruction of phylogenetic trees was used as a simple
and effective approach to show sequence relationships graphi-
cally. Three distinct phylogenetic trees were generated from
multiple alignments of amino acid sequences taking into account
the whole molecule, head, and rod (see Fig. 2). The junction
between head and rod was set at proline 842 at the end of the
MyLC binding region (see below). We had to face a few
limitations: two isoforms, canine MyHC α-cardiac and murine
MyHC 2A, could be not used for the whole molecule com-
parison as the sequences are not complete. Canine α-cardiac
lacked of a portion of the head and was used only for rod
analysis, whereas murine 2A, lacking of a portion of the rod, was
used only for head analysis. Human MyHC 2M could not be
used either, as only a fragment corresponding to the tail is
available. Interestingly, the alignment of the tails of the three
MyHC 2M orthologs (human, canine, and feline, not shown)
revealed that the human isoform has a large deletion of 29 aa
starting at 1007 in addition to the mutation at the C terminus
described by Stedman and co-workers [7].
Despite these limitations, the number of sarcomeric MyHC
isoforms analyzed here is higher than in any previous study
(compare, for example, with Qin et al. [4]). With regard to the
newly sequenced canineMyHC isoforms, the phylogenetic trees
confirmed their positions within each specific group of
orthologous MyHC isoforms. From a more general point of
view the phylogenetic trees confirmed the classification into
three subfamilies, i.e., fast/developmental, cardiac, and masti-
catory, previously described [4]. Some details deserve com-
ments. MyHC EO isoforms form a well-separated group within
the fast/developmental subfamily when both the whole molecule
and the head are considered. When the tail sequences are
compared, however, the MyHC EO isoforms are organized in a
completely separate cluster, suggesting a distinct evolution of
the tail. Emb, Peri, 2A, 2X, and 2B isoforms form groups
reliably separated (reliability 97-100%) when the whole
sequences are compared. The difference becomes less defined
when only the head or the tail sequences are compared. In
particular, porcine MyHC 2B cannot be separated from the 2X
isoforms in the tree of the head domain (Fig. 2B).
Sequence comparison in specific MyHC regions
As stated in the introduction, the availability of the sequences
of the orthologous sarcomeric MyHC isoforms in several
mammalian species offers a unique chance to identify the
structural details that characterize each group of orthologs. To
this aim, comparisons were carried out for the regions that are
considered relevant to determine the functional diversity amongisoforms in view of their greater variability and the effects of
mutation experiments (see above, introduction). Previous
studies [9,16,24] have shown that the surface loops are very
diverse among myosin paralogs but almost identical among
myosin orthologs. It should be thus possible to identify which
motifs are typical of each group of orthologs and represent a kind
of “molecular signature” of each group. In this study, the
sequences of 38 MyHC isoforms (4 fast 2B, 8 fast 2X, 6 fast 2A,
2 Peri, 3 Emb, 3 EO, 3 (or 4) α-cardiac, 7 β/1, and 2 2M
isoforms) were aligned to compare the three superficial loops
indicated as loop 1 at the junction between the 25 K and the 50 K
domains, loop 2 at the junction between the 50 K and the 20 K
domains, and loop 3, also called the secondary actin-binding
loop. Further comparisons were carried out between the
sequences of the converter domain, the MyLC binding region,
and the proximal region of the S2 segment.
Amino acid numbering can create some difficulties as
differences appear between MyHC isoforms a few residues after
the methionine at the N terminus (M1). Thus, to avoid ambiguity
the sequence of human MyHC 2B was chosen as a reference in
residue numbering and it is specified in the text when other
references were used.
Loop 1
The alignments of the residues of loop 1 are shown in Fig.
3A. The loop starts with a negatively charged residue, E204, in
human MyHC 2B. If the end is placed at G217, the length
varies between 14 aa in 2B, 2X, 2A, and Peri isoforms; 13 aa in
EO and α-cardiac isoforms; 12 in Emb and β/1; and only 8 aa
in MyHC 2M. A common motif (EKKKEE), characterized by
1 negatively charged residue (E204) followed by 3 positively
charged residues (K) and 2 negatively charged (E208 and
E209), can be recognized at the N/5′ side of the loop, whereas a
single positively charged residue (K214) marks the C/3′ side of
the loop (motif KMQG, see scheme in Fig. 3B). The central
part of the loop is composed of 4 residues in the three adult fast
isoforms (2B, 2X, 2A) and in MyHC-Peri. Glycine is the last of
the 4 residues in virtually all isoforms, except Emb and α-
cardiac, whereas a proline is consistently present in 2B and EO
MyHC isoforms and occasionally in 2A, 2X, and develop-
mental isoforms. MyHC EO is closely similar to fast adult
isoforms but 1 of the 2 acid residues is missing (209) and
proline is accompanied by the hydrophilic glutamine (Q).
MyHC Emb shows further diversity as, in addition to the lack
of the second acidic residue at 209, the C/3′-side motif is
identical to cardiac and 2M isoforms (KG). An additional basic
residue K is present in the central and more variable part of
loop1, at 212. Thus, in this isoform the electrostatic balance is
clearly shifted toward the positive charges (5:2).
The loop 1 sequences of the two “cardiac” MyHC
isoforms are rather similar to each other. At the N end of
the loop, a motif similar to that present in fast isoforms is
conserved (DRxKKD), with the three positively charged
residues separated by a residue in position 205 and preceded
and followed by a negative charge (Fig. 3B). The C/3′-side
motif is characterized by the positive residue K (the KG
Fig. 2. Phylogenetic trees for (top) the whole MyHC molecule, (bottom left) the head domain, and (bottom right) the tail domain. Numbers are bootstrapping values,
the bars indicate phylogenetic distance.
228 L. Maccatrozzo et al. / Genomics 89 (2007) 224–236motif), whereas the central part is variable (from five to four
residues, respectively, in α and β/1 isoforms) containing hydro-
phobic amino acids and in several animal species also proline.
Loop 1 of MyHC 2M (Fig. 3B) is markedly different from
any other isoform, in the first place because it is much shorter,
with six residues missing. In addition, the initial acidic residue
(corresponding to 205 in MyHC 2B) is missing, two serineresidues replace the lysines followed by a negatively charged D
(at 209 in 2M), the central part is missing, but a positively
charged amino acid (K212) is still present at the C side of the
loop, forming a KG motif. Since MyHC 2M is considered the
oldest isoform from the phylogenetic point of view [4] we can
hypothesize that through phylogenesis the original sequence
KQSSDGKG was modified by insertion of residues particularly
229L. Maccatrozzo et al. / Genomics 89 (2007) 224–236at the N side of the loop. Compared with canine and feline
orthologs, the human MyHC 2M (sequence from [8]) shows an
additional positively charged K to replace G211 and a doublet
TT to replace S208 and S209 (numbering in the MyHC 2M
sequence).
Length, flexibility, amount, and distribution of charges are
likely essential for the function of the loop 1, which, in view ofFig. 3. Loop 1 structure. 38 sequences are aligned in panel A and the scheme of
the specific motif is shown in panel B. The color code is red, basic amino acids
(H, K, R); dark red, nonpolar amino acids (A, C, G, I, L, M, P, V); teal,
uncharged polar amino acids (N, Q, S, T); blue, acidic amino acids (D, E); dark
yellow, aromatic amino acids (Y, W, F). Please note that (i) only uppercase
letters are considered to be aligned, (ii) the residue numbers refer to human
MyHC 2B, (iii) x denotes variable residues, (iv) P is variable in 2X and 2A, and
(v) equine 2A does not show the TS doublet present in all 2A and 2X isoforms.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)its position at the opening of the catalytic site, has been related
to control of ADP release [15]. Actually, striking correlations
between ADP release rate and loop 1 size have been
demonstrated comparing smooth muscle MyHC isoforms [25]
and studying chimeric MyHC with variable loop 1 [18].
Reduction of flexibility of the loop and reversal (but not
removal) of its net positive charge have been shown to result in
slowing the ADP release rate [18]. The functional importance of
the positively charged residues in loop1 has been attributed to a
possible interaction with other charged residues located in front
of loop 1 at the opening of the nucleotide binding site [26]. The
present comparison between sarcomeric MyHC isoforms shows
that the loop 1 length increases from 12 residues in β/1 to 14
residues in MyHC 2B. Such increase in size might be relevant
for the filament sliding velocity and ADP release rate, which
also increase progressively from slow to 2B myosin [27]. If
positive charges are relevant [18], the presence of three negative
charges should, however, set a limit to high values of ADP
release rate in fast MyHC isoforms compared to cardiac MyHC
isoforms, which have only two negative charges. The few
available data on functional properties of 2M myosin suggest
that MyHC 2M should be closer to a fast than to a slow isoform
[12]. To be consistent with the interpretation given above, we
can hypothesize that the effect of the small size of loop 1 (only 8
residues) might be compensated for by the lack of proline and
the presence of only one negative charge.
Loop 3
Loop 3 starts at K568 in fast 2B MyHC isoforms and is
characterized by the marked predominance of the positively
charged residues and the presence of proline (see Fig. 4). A
motif with 4 lysines and 1 glutamate, KPKxxKGK(x)xEAH, is
present in all MyHC isoforms of the cluster of fast/develop-
mental isoforms and can be found also in MyHC 2M. The loop
size is constant in all isoforms, with the exception of MyHC
2M, which has an additional residue (G573 for the MyHC 2M).
No information is available about loop 3 in human MyHC 2M.
The two cardiac MyHC isoforms show partial replacement of
the lysines with arginine, with no changes in charge. Whereas
the first proline at 569 is present in all isoforms (see Fig. 4B),
the second proline (P571) is present only in 2B, 2X, and EO and
the third proline is present only in a few isoforms (one of four
2B, two of eight 2X, one of six 2A, and four of seven β/1, see
Fig. 4B). Thus, loop 3 is highly conserved between MyHC
isoforms expressed in mammalian striated muscles. Apparently,
the size, the positive charge, and the flexibility make loop 3 of
sarcomeric MyHC optimal for interaction with actin, more
precisely with residues 1-28 of a second actin molecule [28].
The number and the locations of the proline residues are the
only substantial diversity among isoforms. In particular, the
change in loop flexibility caused by P571 present only in the
isoforms that generate a higher speed of filament sliding may
have some functional relevance. It is furthermore remarkable
that scallop loop 3 does not align with the corresponding
mammalian sarcomeric peptide. The phylogenetic tree relative
to loop 3 (Supplementary Fig. 4) shows that the separations
Fig. 4. Structure of the second actin-binding loop. 38 sequences are aligned in panel A and the scheme of the specific motif is shown in panel B. The color code is red,
basic amino acids (H, K, R); dark red, nonpolar amino acids (A, C, G, I, L, M, P, V); teal, uncharged polar amino acids (N, Q, S, T); blue, acidic amino acids (D, E);
dark yellow, aromatic amino acids (Y, W, F). Please note that (i) only uppercase letters are considered to be aligned, (ii) the residue numbers in B refer to humanMyHC
2B, and (iii) x denotes variable residues. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
230 L. Maccatrozzo et al. / Genomics 89 (2007) 224–236between MyHC 2M, cardiac isoforms, and the fast/develop-
mental group are significant.
Loop 2
The loop 2 structure is shown in Fig. 5. In human MyHC
2B, which is taken for residue numbering, loop 2 starts on the
N-terminal side at residue G626 after the conserved doublet LF(623 and 624) and ends on the C-terminal side with the
conserved peptide GSSF (F648). The length of the loop is thus
23 aa for MyHC 2B and varies between 22 and 26 aa for the
isoforms of the cluster on chromosome 5. The length is 23 aa for
MyHC α and 22 for MyHC β/1 and reaches the shortest value
for MyHC 2M, with only 17 residues. A more detailed
comparison inside the cluster of fast/developmental isoforms
reveals that in the Emb and Peri isoforms loop 2 is consistently
231L. Maccatrozzo et al. / Genomics 89 (2007) 224–23622 aa long, whereas in EO it is 24 aa long. The interspecies and
interisoform variability is higher among fast 2A, 2X, and 2B
isoforms. In particular, the sequences of murine MyHC 2A and
MyHC 2X show an insertion of 3 residues (SGG) in the central
part of the loop, which thus becomes 26 aa long. The size of
loop 2 in human MyHC 2A is controversial, with either 25 [3]orFig. 5. Loop 2 structure. 38 sequences are aligned in panel A and the scheme of the
panel C. The color code is red, basic amino acids (H, K, R); dark red, nonpolar amin
blue, acidic amino acids (D, E); dark yellow, aromatic amino acids (Y, W, F). Please
numbers refer to human MyHC 2B, and (iii) x denotes variable residues. Some uncer
residues on the N side of E631 are present only in 2X ofMus and Rattus and 2A of B
porcine 2B shows an additional ER doublet, which also needs validation and makes p
the references to colour in this figure legend, the reader is referred to the web vers23 residues [8] (shown in Fig. 5A) due to an insertion of 2 aa in
the central part of the loop. The uncertainty about loop size
(human MyHC 2A) and the lack of alignment (murine MyHC-
2A and canine MyHC-2B, see Fig. 5A) suggest that further
validation is needed before this variability can be considered of
biological/functional relevance.specific motif is shown in panel B. A phylogenetic tree of loop 2 is shown in
o acids (A, C, G, I, L, M, P, V); teal, uncharged polar amino acids (N, Q, S, T);
note that (i) only uppercase letters are considered to be aligned, (ii) the residue
tainties that need validation are indicated in the scheme (B). (1) indicates that six
os, (?) indicates a residue that needs validation in murine 2A and 2X, and finally
orcine 2B different from its orthologs (see tree in panel C). (For interpretation of
ion of this article.)
Fig. 5 (continued).
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part, the central part, and the C-terminal part. Among the three,
the central part shows the highest variability. At the N-terminal
side of the loop, five residues without electrical charge followed
by a negatively charged doublet of glutamate or aspartate (631
and 633) and generally separated by an alanine residue delineate
a motif, xxxxxDxE. The separation between the two negatively
charged residues is given by one residue in 2B, 2X, 2A, Peri,
and Emb MyHC, becomes two in EO and α-cardiac, and three
in Peri and β/1 (thus xxxxxDxPxE), in which a proline is
present between the two negative charges (see Fig. 5B).
The central part of the loop (between E633 and K638) is
formed by a number of residues specific for each isoform
without any difference between species, i.e., no residue for
MyHC- β/1; two for MyHC α-cardiac; three for Peri, Emb, and
EO isoforms; and four for MyHC 2B. Longer sequences can be
found in some species for MyHC 2A and MyHC 2X, with
exceptions represented by murine 2A and 2X (see above). The
sequence of human MyHC 2A is still controversial (see above).
Interestingly, a lysine is present in MyHC Emb.
Five positively charged lysine residues mark the C side of the
loop. In the fast/developmental MyHC isoform group, the C part
is organized according to the motif KKxxKKKGSSF (where xx
are either G/V or G/A), very conserved inside orthologous
isoform groups, whereas in MyHC α-cardiac the motif is
KxKxxKKKGSSF and in MyHC β/1 KxKxKxKKGSSF.MyHC 2M shows a loop 2 sequence (KEEEAPAGSKKQ-
KRGSSFM) perfectly identical in the three orthologs available
until now (cat and dog and human, not shown in Fig. 5, from
[8]), but completely different from any other isoform. The loop
is much shorter (only 17 residues), with 5 residues missing at
the N side, shows an additional negatively charged residue, and
lacks a positively charged residue at the N side, which thus
consists of only 4 positively charged residues. A proline residue
is present in the central part, which is composed of 5 residues.
Loop 2 is a major site of interaction between myosin and
actin. The positively charged lysines are assumed to interact
with the six negatively charged residues close to the actin N
terminus during the initial docking step of actomyosin
interaction [29,30]. The loop is in proximity to the hydrophobic
residues P529, M530, I535, F542, and P543, which contribute
to the stereospecific interaction with A141, I341, I345, and
L349 on the actin surface [30]. Changes in loop size, charge,
and flexibility have been shown to influence ATPase activity
with little or no effect on filament sliding velocity [17]. If
isoforms are ordered with increasing ATPase activity from
MyHC β/1 to α-cardiac, 2A, 2X, and 2B [31,32], one can
observe that the size of the central part regularly increases in
direct relation to the ATPase activity, whereas the size of the N
part and the size of the C part decrease. In other words, the
negatively charged residues at the N side of the loop are more
compact or close to one another and the distance between the
negative N side and the positive C side is greater in the fastest
(MyHC 2B) than in the slowest isoform (MyHC β/1). Loop 2 of
MyHC 2M is very short, but the central part is composed of five
residues; thus it is not shorter than in the isoforms with very
high enzymatic activity, such as 2B. The size of the separation
between the negatively charged N side and the positive side
might explain the high ATPase activity of myosin 2M (see [12]).
In view of the relevance of loop 2 for ATPase activity, it is
possible that loop 2 structure might be responsible not only for
the diversity of ATPase rate between isoforms but also for the
specific sensitivity of ATPase activity to alkali or acid
preincubation. In support of this hypothesis comes the fact that
acid-labile myosin ATPase is characteristic of fast myosin
isoforms, which exhibit groups of two to five consecutive
glycine residues. The presence of such glycine chains makes the
loop unstable and prone to denaturation in acid environment.
The structure of the loop in 2M and β/1 isoforms is made stable
not only by the lack of the glycine chains but also by the presence
of a proline residue in the central part of the loop.
The phylogenetic tree of the loop 2 (Fig. 5C) confirms the
significant separation between the subfamilies fast/develop-
mental, cardiac, and 2M. Inside the fast/developmental sub-
family Emb, Peri, and EO appear as separate groups, whereas the
diversity among 2A, 2X, and 2B is less significant.
Converter domain
Mutation studies in Drosophila [19] and analysis of point
mutations in hypertrophic cardiomyopathy [33] have revealed
how residue changes in the converter domain influence cross-
bridge kinetics. This region was thus comparatively examined in
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714, which comprises the two active thiols C699 and C709,
shows a sequence (CNGVLEGIRICRKGFP) completely con-
served in all isoforms including MyHC 2M (see Supplementary
Fig. 5 and Fig. 6). The peptide 714–726 (SRIxYxD/EFK/
RQRY) is also rather conserved with minor diversity among the
three isoform subfamilies, whereas more important diversity can
be seen in the next peptide (726–759). In the fast/developmental
group the peptide 726–759 shows the structure K/RxLNASAI-
PEGQxIDSKxAxEKLLxSIDxDH/RxQ with some differences
between MyHC EO, which has an additional negative charge
and lacks a positive charge, and the other members of the group.
In the two cardiac isoforms the triplet ASA (731–733) is
replaced by PAA, thus adding a second proline to that present in
all isoforms (P735, see Fig. 6). The diversity becomes evenmore
pronounced when the 726–759 peptide is compared with the
corresponding peptide in MyHC 2M. The peptide is one residue
shorter, lacks three charged residues (two positive and one
negative), and contains an additional proline like the cardiac
isoforms. On the whole, a contribution of the differences in the
converter domain to the functional specificity of myosin 2M
cannot be excluded. The next peptide, 760–780 (YK/RF/
IGHTKVFFKAGLLGL/TLEEM, see Fig. 6), is very conserved
with a few minor residue changes.
MyLC binding regions
The preferential association between MyHC and MyLC
isoforms (see for a review [2]) is well known and might find an
explanation either in isoform coexpression, and thus in
transcriptional regulation, or in a preferential binding between
MyHC and MyLC isoforms. To contribute to the answer to this
question, the comparison between the binding regions of
various MyHC isoforms can be of interest. The long α helix
(Supplementary Fig. 6), which contains the binding sites for
essential and regulatory MyLC, spans from the methionine
(M780) located at the end of the converter and followed by the
positively-negatively charged residues RDEK or RDDK to the
end of the myosin head marked by the proline (P842), which
determines a clear turn of direction of the helix. Fig. 7A shows
the results of the alignment of the sequences of the 38 MyHC
isoforms. A consensus motif (792–802), xQxxxRGxxxR,which
can match the essential light chain as well as calmodulin and is
characterized by hydrophobic and positively charged residues,
can be identified in all MyHC isoforms and can be extended toFig. 6. Scheme showing the primary structure of the converter region in sarcomeric M
Note that the variable part 715–759 is flanked by two peptides (699–714 and 760–KxxQxxxRGxLxRxExxK/R if only the 2B, 2X, and Peri
isoforms are considered. Diversity can be found outside the
consensusmotif, as additional positive charges at 787 are present
on the N side of the consensus motif in the Emb, β/1, α-cardiac,
and 2M isoforms and on the C side at 806 in the 2B, EO, α-
cardiac, and 2M isoforms. A third additional positive charge is
present inside the consensus motif at 795 in 2M isoforms, in
many 2A isoforms, and in some 2X isoforms (see Supplemen-
tary Fig. 6). Thus, cardiac isoforms have two additional positive
residues flanking the consensus motif, whereas among fast/
developmental isoforms an additional positive charge is present
at 787 in Emb and 806 in 2B and EO. In MyHC 2M the positive
charge at 787 corresponds to the lack of it at 782 (numbering of
MyHC 2M).
The RLC binding region starts at the N side with the highly
charged peptide ERRD or ERRE, with the exception of only
Peri, Emb, and 2M, and ends at the C side with the conserved
sequence KI/VKP (see Fig. 7B). A consensus motif, IQxxx
RxxxxxK/R, for binding of the regulatory MyLC can be
recognized in all MyHC isoforms. Diversity can be found in
the fast/developmental family with EO lacking one negative
charge at 835. Cardiac and 2M isoforms lack a positively
charged residue (830). MyHC 2M is clearly different, showing
more positively charged residues and lacking proline 832.
In conclusion, the MyLC binding region appears to be very
conserved among isoform groups, although minor differences in
number and positions of positively charged residues are present.
It is possible that such diversity in charged and hydrophobic
residues contributes to preferential binding of one MyLC
isoform over another.
Proximal S2 segment
Proline 842 represents the transition between the coiled-coil
structure and the separated heads. The angle of about 30°
generated by the proline residue is well above the angle of 11°
compatible with the coiled-coil structure [34]. A direct
involvement of the S2 region in the force generation by myosin
has been considered in several studies [35,36]. The functional
relevance is further suggested by the impact of the mutations of
MyBP-C, which binds to this region of the myosin molecule,
and by mutations in the S2 fragment that might alter the
interaction with the regulatory MyBP-C motif [37]. Some
diversity among isoforms can be found in the peptide comprised
between P842 and the sequence KELEEKMV (starting atyHC isoforms. Color code is as in Figs. 3, 4, and 5. x denotes variable residues.
780) completely conserved in all isoforms.
Fig. 7. Schemes showing the structures of (A) the ELC binding region and (B) the RLC binding region in sarcomeric mammalian MyHC isoforms. Color code as in
Figs. 3, 4, and 5. x denotes variable residue.
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group of isoforms is rather homogeneous (see Fig. 8), with the
exception of residue 861 at which place a negatively charged
residue is present in 2B, 2X, and EO but not in 2A, Peri, and
Emb. An additional negatively charged residue (at 867) is
generally lacking in MyHC 2X. In cardiac isoforms the negative
charge at 861 is also absent and the negative charge at 868 is
shifted toward the C end. The difference between 2M and all
other isoform is very pronounced as the balance between
negative and positive charges (10:10 or 11:10) appears defi-
nitely shifted toward the negative sign (10:8) and clusters of two
or three negative charges appear. Both the stability of the α-
helix structure and the binding with MyBP-C might be affected
by such diversity.
Conclusions
This study provides the first complete sequences of all canine
sarcomeric MyHC isoforms and makes use of the comparison
between the newly obtained set of the sequences with sequences
already published to identify structural features specific to
various groups of MyHC isoforms. The identification of nineFig. 8. Scheme showing the structure of the proximal part of the S2 segment in mam
variable residue.sarcomeric MyHC sequences makes the dog the third species
best known after humans and mice.
As mentioned in the introduction, the interest in the canine
MyHC sequences is high for scientists interested in muscle
physiology and physiopathology as well as for veterinarians
who study dog diseases and for zoologists interested in the large
variability among canine strains. Even sport science is
interested in dog muscles, and the availability of the sequences
offers a straightforward and reliable way to study muscle
specialization and adaptation.
In our view, however, the results obtained from the alignment
of 38 MyHC isoforms are not less important. The number of
isoforms considered goes beyond that considered in previous
investigations and allows the identification of the peptides that
form the basis for structural diversity among isoforms of
sarcomeric MyHC. With the exception of MyHC 2M, the
sarcomeric MyHC form a very homogeneous group with
percentage of identical amino acids above 90% when orthologs
are compared and above 70% when paralogs are compared. The
connection between the structural diversity and the functional
diversity is only speculative unless mutation experiments and
creation of chimeric myosins are performed. The present results,malian sarcomeric MyHC isoforms. Color code as in Figs. 3, 4, and 5. x denotes
235L. Maccatrozzo et al. / Genomics 89 (2007) 224–236however, form in our opinion the essential basis to design such
experimental studies on structure-function relations inside the
highly specialized family of sarcomeric MyHC isoforms.
Methods
Nucleotide sequences were identified and amino acid sequences were
deduced using NCBI databases and tools. The dog genome database (http://
www.ncbi.nlm.nih.gov/projects/genome/guide/dog/) contains either fully
sequenced contigs (from ∼1 kb to several hundreds of kilobases) or assembled
supercontigs of several dozen megabases, interrupted by short gaps. The
BLAST programs [21] were used for database searching against the most recent
genome assembly (CanFam2.0, May 2005).
Human cDNA sequences of MyHC (see Table 1) were the query sequences.
After BLASTN searches, the best scoring alignment for each MyHC isoform
identified the corresponding dog gene. At the same time, information about the
exact chromosomal position in the dog genome was retrieved. The genes have
been fully annotated to identify exons, introns, intron-exon boundaries, and the
5′ and 3′ untranslated regions. Intron sequences were removed to obtain
uninterrupted coding sequences (CDS).
The assembled CDS for each dog MyHC isoform were translated by means
of the BCM Search Launcher Sequence Utilities software (http://searchlauncher.
bcm.tmc.edu/seq-util/seq-util.html) to predict the corresponding MyHC protein.
Multiple protein alignments were generated by means of the DiAlign Algorithm
(http://www.genomatix.de/products/index.html) from all the complete mammals
MyHC isoforms available in the NCBI GenBank database (see Table 1) and the
dog protein sequences obtained with this procedure. In addition to whole protein
alignment, head and rod domains of MyHC were aligned separately and
analyzed. The most variable functional sites of the myosin head—loop 1, loop 2,
loop 3, the converter domain, MLC binding regions, and the proximal S2
segment—were also aligned separately.
Phylogenetic tree reconstructions were carried out using MEGA software
version 3.1 [22]. The tree relationships were reconstructed by the neighbor-
joining methods and the genetic distance was calculated by p distance. The
bootstrap test was performed with 500 replications. The trees were based on the
protein sequence alignment of the mammal MyHC isoforms using scallop
MyHC as the outgroup. For the phylogenetic study only complete amino acid
MyHC sequences were considered, i.e., 37 MyHC sequences from eight distinct
species. Two isoforms, murine fast 2A and canine α-cardiac, were only partially
available and were only occasionally utilized for comparison.Acknowledgment
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